FNDC5
December 8, 2023GLUT2
December 8, 2023
FNDC5
December 8, 2023GLUT2
December 8, 2023
- Pharmacological aspects of the safety of gliflozins
- CaMKII and GLUT1 in heart failure and the role of gliflozins
- Ultrasound-assisted dispersive liquid–liquid microextraction for determination of three gliflozins in human plasma by HPLC/DAD
- Postoperative euglycaemic diabetic ketoacidosis associated with sodium–glucose cotransporter-2 inhibitors (gliflozins): a report of two cases and review of the …
- Meta-analyzing the factors affecting the efficacy of gliflozins in patients with heart failure based on heart failure trials
- Gliflozins for the Treatment of Congestive Heart Failure and Renal Failure in Type 2 Diabetes
- The good, the bad, and the ugly: sodium–glucose cotransporter-2 inhibitors (gliflozins) and perioperative diabetes
- The synthesis of gliflozins
- … II-induced upregulation of SGLT1 and 2 contributes to human microparticle‐stimulated endothelial senescence and dysfunction: protective effect of gliflozins
- Long-term efficacy of gliflozins versus gliptins for Type 2 Diabetes after metformin failure: a systematic review and network meta-analysis
- Possible Preventative/Rehabilitative Role of Gliflozins in OSA and T2DM. A Systematic Literature Review-Based Hypothesis
- Paradigm shift in heart failure treatment: are cardiologists ready to use gliflozins?
- Analytical tools for determination of new oral antidiabetic drugs, glitazones, gliptins, gliflozins and glinides, in bulk materials, pharmaceuticals and biological …
- SAVOR-TIMI to DECLARE-TIMI: A review on cardiovascular outcome trials of incretin-modulators and gliflozins
- Are gliflozins the new statins for diabetes?
- Metabolic effectiveness of gliflozins and gliptins in the routine clinical practice of patients with type 2 diabetes: preliminary results from GIOIA, a prospective multicentre …
- Cardiovascular impact of new drugs (GLP-1 and gliflozins): the ABCD position statement
- Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function
- Gliflozins–a new border stone
- euglycemic Diabetic Ketoacidosis In The Perioperative Period: Why Gliflozins May Not Be So Sweet After All!
- Selecting Patients at Risk of Developing DKA on Gliflozins
- PDB91-EXPLAINING THE DISPARITIES OF MARKET ACCESS FOR GLIFLOZINS IN FRANCE, SPAIN, GERMANY AND THE UNITED-KINGDOM
- A review on analytical methods for determination of oral anti-diabetic drugs like biguanides, gliptins and gliflozins in bulk and in pharmaceutical dosage forms
- Pharmacological characterization of the sodium-glicose co-transporter 2 inhibitors, gliflozins in isolated platelets from healthy volunteers
- Article Details summary of chromatographic analysis methods of anti diabetic gliflozins Empagliflozin, Canagliflozin and Dapagliflozin
- Gliflozins: initial review of literature
- Summary of chromatographic analysis methods of anti diabetic gliflozins Empagliflozin, Canagliflozin and Dapagliflozin
- How we indicate oral antidiabetics today (from metformin to gliptins and gliflozins)
- Antidiabetic drugs from group of gliflozins and their role in pharmacotherapy of diabetes
- Cardiorenal protection with SGLT2 inhibitors (gliflozins): from EMPA-REG OUTCOME to CANVAS
